Immunoregulatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis

International Journal of Antimicrobial Agents

Volumn 33, Issue 4, 2009, Pages 387-389

  Vitali, Beatrice ^a   Perna, Federico ^a   Lammers, Karen ^a   Turroni, Silvia ^a   Gionchetti, Paolo ^a   Brigidi, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; RIFAXIMIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BIFIDOBACTERIUM LONGUM INFANTIS; COLONY FORMING UNIT; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL DISEASE; IMMUNE SYSTEM; IMMUNOREGULATION; INTESTINE CELL; LETTER; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; WILD TYPE;

BIFIDOBACTERIALES INFECTIONS; BIFIDOBACTERIUM; CYTOKINES; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTES, MONONUCLEAR; RIFAMYCINS;

EID: 61749100325     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.10.007     Document Type: Letter

References (7)

1. Gillis J.C., and Brogden R.N. Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs 49 (1995) 467-484
2. Lammers K.M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., et al. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38 (2003) 165-172
3. Nova E., Wärnberg J., Gómez-Martínez S., Díaz L.E., Romeo J., and Marcos A. Immunomodulatory effects of probiotics in different stages of life. Br J Nutr 98 Suppl. 1 (2007) S90-S95
4. Brigidi P., Swennen E., Rizzello F., Bozzolasco M., and Matteuzzi D. Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis. J Chemother 14 (2002) 290-295
5. Vitali B., Turroni S., Dal Piaz F., Candela M., Wasinger V., and Brigidi P. Genetic and proteomic characterization of rifaximin resistance in Bifidobacterium infantis BI07. Res Microbiol 158 (2007) 355-362
6. Vitali B., Turroni S., Serina S., Sosio M., Vannini L., Candela M., et al. Molecular and phenotypic traits of in-vitro-selected mutants of Bifidobacterium resistant to rifaximin. Int J Antimicrob Agents 31 (2008) 555-560
7. Lammers K.M., Helwig U., Swennen E., Rizzello F., Venturi A., Caramelli E., et al. Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol 97 (2002) 1182-1186